Micafungin
میکافانژین
🦠 Antiinfectives For Systemic UseEchinocandin
Market / country: 🇺🇸 USA
Mycamine (US)
🧮 Dose calculator
Invasive fungal infection (aspergillosis, candidaemia, cryptococcosis) — hospital · Regimen source: FDA Micafungin premix · 2.2, Table 1
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to micafungin or other echinocandins. FDA Micafungin premix · 4
Formulations
- 1 mg/mL premixed (50/100/150 mL) — injection 🇺🇸 USA FDA Micafungin premix · 3
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Micafungin premix · 8.1
“Risk Summary Based on findings from animal studies, Micafungin for Injection may cause fetal harm when administered to a pregnant woman (see Data) .”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Micafungin premix · 8.2
“Risk Summary There are no data on the presence of micafungin in human milk, the effects on the breast-fed infant or the effects on milk production .”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Micafungin premix · 8.4
“Pediatric Patients 4 Months of Age and Older The safety and effectiveness of micafungin for injection for the treatment of esophageal candidiasis, candidemia, acute disseminated candidiasis, Candida peritonitis and abscesses, esophageal candidiasis, and for prophylaxis of Candida infections in patients undergoing HSCT …”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Micafungin premix · 8.5
“This may be clinically important with regard to such diseases as congestive heart failure and other conditions requiring restricted sodium intake [ see Warnings and Precautions (5.6 )] .”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA216142
- DailyMed (FDA label)FDA Micafungin premix
- MedlinePlus (NIH)Micafungin Injection
- WHO ATC/DDDJ02AX05
- Darooyab (Iran)Micafungin
🇮🇷 Not found in Iran list Darooyab · G-728/Micafungin
Darooyab lists no registered dosage form or brand for this drug. This does not prove it is unavailable.
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Micafungin premix · 3FDA Micafungin premix · 2.2, Table 1FDA Micafungin premix · 2.3, Table 2FDA Micafungin premix · 2FDA Micafungin premix · 4FDA Micafungin premix · 8.1FDA Micafungin premix · 8.2FDA Micafungin premix · 8.4FDA Micafungin premix · 8.5FDA Micafungin premix · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-728/Micafungin
- Clinical review⚠ Unverified